FDA 510(k)

科博斯BKV，科博斯EBV/BKV控制试剂盒，科博斯缓冲阴性控制试剂盒

K号: K202215 · 2020-09-02

决定日期2020-09-02

产品代码QMI

咨询委员会抱歉，您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit is the device name listed in this FDA 510(k) record. The listed applicant is Roche Molecular Systems, Inc.. It received FDA 510(k) clearance on 2020-09-02 under 510(k) number K202215. The device is classified under product code QMI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?

cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit is a medical device that received FDA 510(k) clearance on 2020-09-02. The listed applicant is Roche Molecular Systems, Inc.. The 510(k) number is K202215.

When did cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit receive FDA 510(k) clearance?

cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit received FDA 510(k) clearance on 2020-09-02, under 510(k) number K202215.

Who is the listed applicant for cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?

FDA 510(k)记录中列出罗氏分子系统有限公司为申请人。这本身并不足以确立该设备制造商的身份。

What is the FDA product code for cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?

The FDA product code for cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit is QMI.

列明Roche Molecular Systems, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K260045cobas® Cdiff 核酸检测，用于 cobas® Liat® 系统（07454945190）；cobas® Cdiff 阳性及阴性对照试剂盒，用于 cobas® Liat® 系统（07454970190）K260047cobas Strep A 核酸检测，用于cobas Liat系统（07341911190）；cobas Strep A 质量控制试剂盒（07402678190）K260021cobas® BV/CV K260917cobas CT/NG 用于 cobas 5800/6800/8800 系统；cobas TV/MG 用于 cobas 5800/6800/8800 系统 K253756cobas liat CT/NG 核酸检测 K253759科博斯利亚特CT/NG/MG核酸检测

查看所有 36 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。